MAP3K7 (mitogen-activated protein kinase kinase kinase 7)
|
Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
6885 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
Mitogen-activated protein kinase kinase kinase 7 |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
MAP3K7 |
SynonymsGene synonyms aliases
|
CSCF, FMD2, MEKK7, TAK1, TGF1a |
ChromosomeChromosome number
|
6 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
6q15 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase mediates the signaling transduction induced by TGF beta and morphogenetic protein (BMP), and controls a variety of cell functions including transcription regulation and apoptosis. In response to IL-1, this protein forms a kinase complex including TRAF6, MAP3K7P1/TAB1 and MAP3K7P2/TAB2; this complex is required for the activation of nuclear factor kappa B. This kinase can also activate MAPK8/JNK, MAP2K4/MKK4, and thus plays a role in the cell response to environmental stresses. Four alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs886039230 |
G>A,C,T |
Pathogenic |
Coding sequence variant, intron variant, missense variant |
rs886039231 |
C>G |
Pathogenic |
5 prime UTR variant, coding sequence variant, missense variant |
rs886039232 |
A>T |
Pathogenic |
5 prime UTR variant, coding sequence variant, missense variant |
rs886039233 |
C>G |
Pathogenic |
Coding sequence variant, missense variant |
rs886039234 |
TCTTCC>- |
Pathogenic |
5 prime UTR variant, inframe deletion, coding sequence variant |
rs886039235 |
C>A |
Pathogenic |
5 prime UTR variant, coding sequence variant, missense variant |
rs886039236 |
AAC>- |
Pathogenic |
5 prime UTR variant, inframe deletion, coding sequence variant |
rs886039237 |
A>C,T |
Pathogenic |
Coding sequence variant, missense variant |
rs1057517758 |
C>T |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs1064795771 |
C>T |
Likely-pathogenic |
Coding sequence variant, 5 prime UTR variant, missense variant |
rs1180249151 |
C>A,T |
Likely-pathogenic |
Splice acceptor variant |
rs1554184177 |
T>C |
Likely-pathogenic |
Missense variant, coding sequence variant |
rs1582233787 |
AAC>- |
Likely-pathogenic |
Coding sequence variant, 5 prime UTR variant, inframe deletion |
|
miRNAmiRNA information provided by mirtarbase database.
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0000186 |
Process |
Activation of MAPKK activity |
IDA |
8663074, 9079627 |
GO:0000187 |
Process |
Activation of MAPK activity |
IDA |
9079627 |
GO:0000187 |
Process |
Activation of MAPK activity |
TAS |
|
GO:0000287 |
Function |
Magnesium ion binding |
IEA |
|
GO:0002223 |
Process |
Stimulatory C-type lectin receptor signaling pathway |
TAS |
|
GO:0002726 |
Process |
Positive regulation of T cell cytokine production |
IMP |
15125833 |
GO:0002755 |
Process |
MyD88-dependent toll-like receptor signaling pathway |
TAS |
|
GO:0004672 |
Function |
Protein kinase activity |
IDA |
10094049 |
GO:0004674 |
Function |
Protein serine/threonine kinase activity |
EXP |
10702308, 11460167, 20538596 |
GO:0004674 |
Function |
Protein serine/threonine kinase activity |
TAS |
|
GO:0004709 |
Function |
MAP kinase kinase kinase activity |
EXP |
11460167 |
GO:0004709 |
Function |
MAP kinase kinase kinase activity |
IBA |
21873635 |
GO:0004709 |
Function |
MAP kinase kinase kinase activity |
IDA |
11460167 |
GO:0005515 |
Function |
Protein binding |
IPI |
10094049, 11460167, 12496252, 15075345, 15764709, 16840345, 16845370, 17079228, 17110930, 17158449, 17449468, 17709393, 18286207, 18591963, 18758450, 19820695, 21512573, 21903422, 22081109, 22158122, 22904686, 25241761, 26334375, 27426733 |
GO:0005524 |
Function |
ATP binding |
IEA |
|
GO:0005634 |
Component |
Nucleus |
HDA |
21630459 |
GO:0005671 |
Component |
Ada2/Gcn5/Ada3 transcription activator complex |
IDA |
18838386 |
GO:0005829 |
Component |
Cytosol |
IDA |
|
GO:0005829 |
Component |
Cytosol |
TAS |
|
GO:0005886 |
Component |
Plasma membrane |
IDA |
|
GO:0007179 |
Process |
Transforming growth factor beta receptor signaling pathway |
TAS |
9466656 |
GO:0007223 |
Process |
Wnt signaling pathway, calcium modulating pathway |
TAS |
|
GO:0007249 |
Process |
I-kappaB kinase/NF-kappaB signaling |
TAS |
|
GO:0007250 |
Process |
Activation of NF-kappaB-inducing kinase activity |
IMP |
10094049, 15125833 |
GO:0007252 |
Process |
I-kappaB phosphorylation |
IDA |
11460167 |
GO:0007254 |
Process |
JNK cascade |
IBA |
21873635 |
GO:0007254 |
Process |
JNK cascade |
IDA |
9079627 |
GO:0007254 |
Process |
JNK cascade |
TAS |
|
GO:0008385 |
Component |
IkappaB kinase complex |
IPI |
10094049 |
GO:0010008 |
Component |
Endosome membrane |
TAS |
|
GO:0016032 |
Process |
Viral process |
IEA |
|
GO:0016239 |
Process |
Positive regulation of macroautophagy |
ISS |
|
GO:0016579 |
Process |
Protein deubiquitination |
TAS |
|
GO:0030971 |
Function |
Receptor tyrosine kinase binding |
IPI |
18762249 |
GO:0032743 |
Process |
Positive regulation of interleukin-2 production |
IMP |
15125833 |
GO:0038095 |
Process |
Fc-epsilon receptor signaling pathway |
TAS |
|
GO:0042802 |
Function |
Identical protein binding |
IPI |
27426733 |
GO:0043123 |
Process |
Positive regulation of I-kappaB kinase/NF-kappaB signaling |
IBA |
21873635 |
GO:0043123 |
Process |
Positive regulation of I-kappaB kinase/NF-kappaB signaling |
IMP |
14982987 |
GO:0043276 |
Process |
Anoikis |
ISS |
|
GO:0043507 |
Process |
Positive regulation of JUN kinase activity |
IDA |
11460167 |
GO:0043507 |
Process |
Positive regulation of JUN kinase activity |
IMP |
10094049 |
GO:0043966 |
Process |
Histone H3 acetylation |
IDA |
18838386 |
GO:0050852 |
Process |
T cell receptor signaling pathway |
NAS |
15125833 |
GO:0050852 |
Process |
T cell receptor signaling pathway |
TAS |
|
GO:0051092 |
Process |
Positive regulation of NF-kappaB transcription factor activity |
TAS |
|
GO:0051403 |
Process |
Stress-activated MAPK cascade |
IDA |
9079627 |
GO:0070423 |
Process |
Nucleotide-binding oligomerization domain containing signaling pathway |
TAS |
|
GO:0070498 |
Process |
Interleukin-1-mediated signaling pathway |
TAS |
|
GO:0097110 |
Function |
Scaffold protein binding |
IDA |
23776175 |
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
O43318 |
Protein name |
Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1) |
Protein function |
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR). Ceramides are also able to activate MAP3K7/TAK1. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs, c-jun N-terminal kinases (JNKs) and I-kappa-B kinase complex (IKK). Both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1), while nuclear factor-kappa B is activated by IKK. MAP3K7 activates also IKBKB and MAPK8/JNK1 in response to TRAF6 signaling and mediates BMP2-induced apoptosis. In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B. Promotes TRIM5 capsid-specific restriction activity. Phosphorylates RIPK1 at 'Ser-321' which positively regulates RIPK1 interaction with RIPK3 to promote necroptosis but negatively regulates RIPK1 kinase activity and its interaction with FADD to mediate apoptosis (By similarity). |
PDB |
2EVA
,
2YIY
,
4GS6
,
4L3P
,
4L52
,
4L53
,
4O91
,
5E7R
,
5GJD
,
5GJF
,
5GJG
,
5J7S
,
5J8I
,
5J9L
,
5JGA
,
5JGB
,
5JGD
,
5JH6
,
5JK3
,
5V5N
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF07714 |
PK_Tyr_Ser-Thr |
36 → 284 |
Protein tyrosine and serine/threonine kinase |
Domain |
|
Sequence |
|
Sequence length |
606 |
Interactions |
View interactions |
|
|